He has been the head of the department at Great Ormond Street since 2007 until he joined Sidra. During this period he led the department to the largest ever expansion and restructure of the service to attract 3 main nationally funded programs that included gut rehabilitation and small bowel transplant, intestinal pseudo-obstruction. He then became the founder and the director of the first worldwide pioneering program for Hematopoietic Stem Cell Transplant for autoimmune and inflammatory gut diseases. He was also the director of the department international collaboration “ImproveCareNow”, which involves 87 pediatric gastrointestinal units in the United States, with GOSH being the only center outside the United States. This collaboration sets the standards of management of children with inflammatory bowel diseases and is a unique quality improvement and research tool that attracts more than 20,000 patients. He was also the co-founder of the European GENIUS group that oversees the diagnosis and the treatment of children with Early onset inflammatory bowel diseases.
Dr. Elawad was a member of the clinical committee of ImproveCareNow, member of the council of CAPGAN and member of the inflammatory bowel disease working group for BSPGHAN. He was also the co-author of the worldwide strategy for implementation of pediatric endoscopy produced by the FISPGHAN.
Dr. Elawad has been a senior lecturer at the Institute of Child Health – University College of London and his main research areas of interest are autoimmune gut disorders, genetics of inflammatory bowel disease, Early Onset Inflammatory Bowel Disease and GI food allergy. He has many publications in the field of inflammatory bowel disease, molecular genetics of early onset inflammatory bowel disease, Hematopoietic Stem Cell Transplant for refractory inflammatory bowel diseases and food allergy.
Twitter
Share Your Review
Please do not post:
Thank you once again for doing your part to keep Medarabia the most trusted medical source.